Clinical Trials Directory

Trials / Completed

CompletedNCT01746069

Effectiveness of Messages to Mobile Phone in Smoke Cessation

Evaluation of a Reinforcement Program Using Text Messages Through Mobile Phone in Smoking Cessation Programs in Primary Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
320 (actual)
Sponsor
Basque Health Service · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Smoking remains a major risk factor for chronic diseases and is a real problem for health systems. The use of emerging technologies, such as mobile phone , may have a important role in smoking cessation programs through sending reinforcement messages when patients quits smoking. Main objective: To evaluate the effectiveness of a combined 6 months smoking cessation program including health advice provided by a doctor and sending support messages to mobile phone of patients. Methods: Study design: Randomized single blind clinical trial. Study population: Patients over 18 who are willing to start a smoking cessation program, who have mobile phone, who are able to receive and send messages, and who have a score greater than 5 or equal to 5 on the Richmond scale. Sample size: 160 patients per arm to detect a difference in the percentage of smoking cessation than 10% (14.9% vs. 4.9%) between the two groups. Intervention: Experimental group: Health advice and support messages to mobile phone patients. Control group: Health advice. Assessment of the primary endpoint: At 6 months (positive/negative coximetry test). Statistical analysis: The analysis of the primary endpoint (positive / negative coximetry test) will be performed using logistic regression.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuit smoking combined cessation programmeSupport sms messages to patient's mobile phone and health advice
BEHAVIORALhealth adviceroutine clinical practice

Timeline

Start date
2013-03-01
Primary completion
2015-03-01
Completion
2015-10-01
First posted
2012-12-10
Last updated
2015-10-21

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01746069. Inclusion in this directory is not an endorsement.